Cargando…

Pre-Vaccine Positivity of SARS-CoV-2 Antibodies in Alberta, Canada during the First Two Waves of the COVID-19 Pandemic

We systematically evaluated SARS-CoV-2 IgG positivity in a provincial cohort to understand the local epidemiology of COVID-19 and support evidence-based public health decisions. Residual blood samples were collected for serology testing over 5-day periods monthly from June 2020 to January 2021 from...

Descripción completa

Detalles Bibliográficos
Autores principales:	Charlton, Carmen L., Nguyen, Leonard T., Bailey, Ashley, Fenton, Jayne, Plitt, Sabrina S., Marohn, Carol, Lau, Cheryl, Hinshaw, Deena, Lutsiak, Christie, Simmonds, Kimberley, Kanji, Jamil N., Zelyas, Nathan, Lee, Nelson, Mengel, Michael, Tipples, Graham
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552659/ https://www.ncbi.nlm.nih.gov/pubmed/34406813 http://dx.doi.org/10.1128/spectrum.00291-21

Ejemplares similares

Characterization of Swine Influenza A(H1N2) Variant, Alberta, Canada, 2020
por: Kanji, Jamil N., et al.
Publicado: (2021)

Decline of Influenza and Respiratory Viruses With COVID-19 Public Health Measures: Alberta, Canada
por: Doroshenko, Alexander, et al.
Publicado: (2021)

Detection of SARS-CoV-2 antibodies formed in response to the BNT162b2 and mRNA-1237 mRNA vaccine by commercial antibody tests
por: Kanji, Jamil N., et al.
Publicado: (2021)

Epidemiology of pertussis in Alberta, Canada 2004–2015
por: Liu, Xianfang C., et al.
Publicado: (2017)

Correlation of school absenteeism and laboratory results for Flu A in Alberta, Canada
por: Birk-Urovitz, Elizabeth, et al.
Publicado: (2017)

Herpes zoster vaccine (HZV): utilization and coverage 2009 – 2013, Alberta, Canada
por: Liu, Xianfang C, et al.
Publicado: (2014)

Number of COVID-19 cases required in a population to detect SARS-CoV-2 RNA in wastewater in the province of Alberta, Canada: Sensitivity assessment
por: Li, Qiaozhi, et al.
Publicado: (2023)

Evaluation of Six Commercial Mid- to High-Volume Antibody and Six Point-of-Care Lateral Flow Assays for Detection of SARS-CoV-2 Antibodies
por: Charlton, Carmen L., et al.
Publicado: (2020)

2514. Pediatric Medically Attended Shingles in Alberta, Canada 2016; Preliminary Results
por: Booth, Stephanie, et al.
Publicado: (2018)

Comparison of SARS-CoV-2 spike antibody quantitative titer reporting using the World Health Organization International Standard Units by four commercial assays
por: Zhuo, Ran, et al.
Publicado: (2022)

2454. Pertussis Vaccine Effectiveness and Waning Immunity in Alberta, Canada: 2004–2015
por: Bell, Christopher A, et al.
Publicado: (2018)

Bordetella pertussis in sporadic and outbreak settings in Alberta, Canada, July 2004 – December 2012
por: Fathima, Sumana, et al.
Publicado: (2014)

Epidemiology of ticks submitted from human hosts in Alberta, Canada (2000–2019)
por: Kanji, Jamil N., et al.
Publicado: (2022)

Changes in norovirus genotype diversity in gastroenteritis outbreaks in Alberta, Canada: 2012–2018
por: Hasing, Maria E., et al.
Publicado: (2019)

A longitudinal seroepidemiology study to evaluate antibody response to SARS-CoV-2 virus infection and vaccination in children in Calgary, Canada from July 2020 to April 2022: Alberta COVID-19 Childhood Cohort (AB3C) Study
por: Doucette, Emily J., et al.
Publicado: (2023)

Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada
por: Kirwin, Erin, et al.
Publicado: (2019)

938. Identifying Gaps in the Treatment of Hepatitis C in Patients Co-Infected with HIV in Edmonton, Alberta
por: Savaryn, Bohdan, et al.
Publicado: (2020)

Use of laboratory and administrative data to understand the potential impact of human parainfluenza virus 4 on cases of bronchiolitis, croup, and pneumonia in Alberta, Canada
por: Fathima, Sumana, et al.
Publicado: (2016)

Correction to: Comparing methods to estimate incremental inpatient costs and length of stay due to methicillin-resistant Staphylococcus aureus in Alberta, Canada
por: Kirwin, Erin, et al.
Publicado: (2019)

Emergence of a Novel Recombinant Norovirus GII.P16-GII.12 Strain Causing Gastroenteritis, Alberta, Canada
por: Pabbaraju, Kanti, et al.
Publicado: (2019)

Incidence of myeloproliferative neoplasms in Calgary, Alberta, Canada
por: Heppner, Jonathan, et al.
Publicado: (2019)

Incidence of chronic myeloid leukemia in Calgary, Alberta, Canada
por: Nguyen, Leonard Tu, et al.
Publicado: (2018)

Effect of not vortexing nasopharyngeal and throat swabs on SARS-CoV-2 nucleic acid detection: A pilot study
por: Kanji, Jamil N., et al.
Publicado: (2022)

Test volume data for 51 most commonly ordered laboratory tests in Calgary, Alberta, Canada
por: Ma, Irene, et al.
Publicado: (2019)

Wastewater-Based Surveillance Is an Effective Tool for Trending COVID-19 Prevalence in Communities: A Study of 10 Major Communities for 17 Months in Alberta
por: Pang, Xiaoli, et al.
Publicado: (2022)

Evolving strategy for an evolving virus: Development of real-time PCR assays for detecting all SARS-CoV-2 variants of concern
por: Pabbaraju, Kanti, et al.
Publicado: (2022)

Feasibility and Field Performance of a Simultaneous Syphilis and HIV Point-of-Care Test Based Screening Strategy in at Risk Populations in Edmonton, Canada
por: Bergman, Joshua, et al.
Publicado: (2013)

Precision Response to the Rise of the SARS-CoV-2 B.1.1.7 Variant of Concern by Combining Novel PCR Assays and Genome Sequencing for Rapid Variant Detection and Surveillance
por: Zelyas, Nathan, et al.
Publicado: (2021)

Household transmission of Streptococcus pneumoniae, Alberta, Canada.
por: Kellner, J D, et al.
Publicado: (1999)

Outbreak of Neisseria meningitidis, Edmonton, Alberta, Canada
por: Tyrrell, Gregory J., et al.
Publicado: (2002)

Asthma-related productivity losses in Alberta, Canada
por: Thanh, Nguyen X, et al.
Publicado: (2009)

Echinococcus multilocularis in Urban Coyotes, Alberta, Canada
por: Catalano, Stefano, et al.
Publicado: (2012)

Environmental Determinants of Bicycling Injuries in Alberta, Canada
por: Romanow, Nicole T. R., et al.
Publicado: (2012)

Newborn Screening: Current Status in Alberta, Canada
por: De Souza, Andy, et al.
Publicado: (2019)

Economic burden of chronic pain in Alberta, Canada
por: Thanh, Nguyen Xuan, et al.
Publicado: (2022)

False negative rate of COVID-19 PCR testing: a discordant testing analysis
por: Kanji, Jamil N., et al.
Publicado: (2021)

Tracking SARS-CoV-2 Omicron lineages using real-time reverse transcriptase PCR assays and prospective comparison with genome sequencing
por: Zelyas, Nathan, et al.
Publicado: (2023)

HPV Vaccine utilization, Alberta 2008/09 – 2013/14 School year
por: Liu, Xianfang C., et al.
Publicado: (2016)

The Evolution of Integrated Chronic Disease Prevention in Alberta, Canada
por: Raine, Kim, et al.
Publicado: (2006)

Incremental costs of hospital-acquired complications in Alberta, Canada
por: Jackson, T, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_vf39hlohr14jnqfker8krnb1o9